About Pho'nomenal
Pho'nomenal is a private company based in Bellevue, Washington. It has reported $570,000 raised in four offerings on Form D since December 2017.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 2, 2023 | May 10, 2023 | $470,000of $1.8M target | 2 | $235K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Not yet | Feb 19, 2020 | $0of $800K target | 0 | — | DebtRule 506(b) | Form D ↗ |
| Jan 20, 2019 | Feb 4, 2019 | $75,000of $1.0M target | 3 | $25,000 | EquityRule 506(b) | Form D ↗ |
| Dec 26, 2017 | Dec 27, 2017 | $25,000of $500K target | 1 | $25,000 | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $570,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Pho'nomenal's Form D filed May 10, 2023.
Earlier filings also listed Lindsey Schwartz (director, last listed Feb 2020), Jamie Colbourne (director, last listed Feb 2020), Gerry Adams (executive officer and director, last listed Feb 2020), Dan Shorett (executive officer and director, last listed Feb 2020), David Howitt (director, last listed Feb 2019) and Arthur Rubinfeld (director, last listed Feb 2019).